(19)
(11)
EP 1 536 825 A1
(12)
(43)
Date of publication:
08.06.2005
Bulletin 2005/23
(21)
Application number:
02753441.1
(22)
Date of filing:
07.08.2002
(51)
International Patent Classification (IPC)
7
:
A61K
38/21
,
A61K
39/395
,
A61K
39/00
,
C07K
1/00
,
C07K
16/00
(86)
International application number:
PCT/US2002/025154
(87)
International publication number:
WO 2004/022088
(
18.03.2004
Gazette 2004/12)
(84)
Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI
(71)
Applicant:
Tanox, Inc.
Houston, TX 77081-2225 (US)
(72)
Inventors:
CHANG, Tse, Wen
Taipei, Taiwan (TW)
YU, Liming
La Jolla, CA 92037 (US)
(74)
Representative:
Adams, Harvey Vaughan John et al
Mathys & Squire,120 Holborn
London EC1N 2SQ
London EC1N 2SQ (GB)
(54)
INTERFERON AND IMMUNOGLOBULIN FC FRAGMENT HYBRID